Zydus Lifesciences Ltd banner

Zydus Lifesciences Ltd
NSE:ZYDUSLIFE

Watchlist Manager
Zydus Lifesciences Ltd Logo
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Watchlist
Price: 900.3 INR -0.38% Market Closed
Market Cap: ₹905.9B

Profitability Summary

Zydus Lifesciences Ltd's profitability score is 61/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

61/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

61/100
Profitability
Score
61/100
Profitability
Score

Margins

Earnings Waterfall
Zydus Lifesciences Ltd

Margins Comparison
Zydus Lifesciences Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IN
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
909.1B INR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
829.8B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
579B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
296B USD
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
229.3B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
214.5B GBP
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.7B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
117.8B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Zydus Lifesciences Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
909.1B INR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
829.8B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
579B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
296B USD
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
229.3B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
214.5B GBP
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.7B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
117.8B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Zydus Lifesciences Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett